![STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD - STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2a5fc7cf-3a1d-4ac8-8e69-86a3d3616cfe/gr1_lrg.jpg)
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD -
Yan Xu - Vice President, Global Head of Clinical Pharmacology - Simcere Pharmaceutical Group | LinkedIn
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas | Chemical Reviews
![Skin prick test digital imaging system with manual, semiautomatic, and automatic wheal edge detection and area measurement | Request PDF Skin prick test digital imaging system with manual, semiautomatic, and automatic wheal edge detection and area measurement | Request PDF](https://i1.rgstatic.net/publication/324175782_Skin_prick_test_digital_imaging_system_with_manual_semiautomatic_and_automatic_wheal_edge_detection_and_area_measurement/links/5f75895292851c14bca408ec/largepreview.png)